Safety, Tolerability, Pharmacokinetics and Immunogenicity Study of GB002 Recombinant Peptide Inhalation Solution in Healthy Subjects

NCT06423261 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

100

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: GB002 Recombinant Peptide Inhalation Solution
DRUG: Placebo

Sponsor

Zhejiang Echon Biopharm Limited